[The effect of various types of stress-limiting therapy on the outcome of myocardial infarction].
A method for computed determination of death probability was used to examine the effects of various modalities of stress-limiting therapy on mortality rates within a month after myocardial infarction. The examination was made in 591 patients with large myocardial infarction. A significant decrease in mortality rates was seen in patients on finoptin and phosphocreatine (by 9.6 and 11.2, respectively) as compared to the expected drop. Other agents given within the first hours of myocardial infarction such as beta-blockers, opioid peptides, sodium oxybutyrate, piracetam, antioxidants were demonstrated to cause no reduction in mortality rates.
V A
VA
Riabinin
A P
AP
Golikov
D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D010725:Phosphocreatine / Q000627:therapeutic use*; D010889:Piracetam / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012978:Sodium Oxybate / Q000627:therapeutic use; D013312:Stress, Physiological / Q000188:drug therapy* / Q000209:etiology; D014700:Verapamil / Q000627:therapeutic use*
D000975:Antioxidants; D010725:Phosphocreatine; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; D012978:Sodium Oxybate; D011433:Propranolol; D014700:Verapamil; C040996:enkephalin-Leu, Ala(2)-Arg(6)-; D010889:Piracetam
Vliianie razlichnykh variantov stress-limitiruiushcheĭ terapii na iskhod infarkta miokarda.